[Gingival recession during progesterone-estrogen therapy].
D004092:20-alpha-Dihydroprogesterone / Q000009:adverse effects; D000328:Adult; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects*; D004338:Drug Combinations; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D005882:Gingival Diseases / Q000139:chemically induced*; D006801:Humans; D009640:Norethindrone / Q000009:adverse effects
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003280:Contraceptives, Oral, Synthetic; D004338:Drug Combinations; D004092:20-alpha-Dihydroprogesterone; C020416:norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination; D004997:Ethinyl Estradiol; D009640:Norethindrone
Recessione gengivale in corso di terapia estroprogenstinica.